Christopher McCormick
Overview
Explore the profile of Christopher McCormick including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
403
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gore J, Petitpas K, McCormick C, Chapman H
R I Med J (2013)
. 2024 Oct;
107(11):19-23.
PMID: 39467192
Functional Neurological Disorder (FND) is a common condition encountered by rehabilitation therapists (physical therapists-PT, occupational therapists-OT, and speech and language pathologists-SLP) in pediatric practice. In an effort to bridge the...
2.
Asciak L, Domingo-Roca R, Dow J, Brodie R, Paterson N, Riches P, et al.
J Mech Behav Biomed Mater
. 2024 Apr;
154:106531.
PMID: 38588633
Despite polyester vascular grafts being routinely used in life-saving aortic aneurysm surgeries, they are less compliant than the healthy, native human aorta. This mismatch in mechanical behaviour has been associated...
3.
Asciak L, Gilmour L, Williams J, Foster E, Diaz-Garcia L, McCormick C, et al.
R Soc Open Sci
. 2023 Aug;
10(8):230929.
PMID: 37593713
Many solid tumours (e.g. sarcoma, carcinoma and lymphoma) form a disorganized neo-vasculature that initiates uncontrolled vessel formation to support tumour growth. The complexity of these environments poses a significant challenge...
4.
McQueen A, Escuer J, Schmidt A, Aggarwal A, Kennedy S, McCormick C, et al.
J Control Release
. 2022 Aug;
349:992-1008.
PMID: 35921913
Since the introduction of percutaneous coronary intervention (PCI) for the treatment of obstructive coronary artery disease (CAD), patient outcomes have progressively improved. Drug eluting stents (DES) that employ anti-proliferative drugs...
5.
King D, McCormick C, McGinty S
Pharm Res
. 2022 Jan;
39(1):25-40.
PMID: 34997423
Drug-filled implants (DFIs) have emerged as an innovative approach to control the delivery of drugs. These devices contain the drug within the structure of the implant itself and avoid the...
6.
McQueen A, Escuer J, Aggarwal A, Kennedy S, McCormick C, Oldroyd K, et al.
Int J Pharm
. 2021 Apr;
601:120575.
PMID: 33845150
The advent of drug-eluting stents (DES) has revolutionised the treatment of coronary artery disease. These devices, coated with anti-proliferative drugs, are deployed into stenosed or occluded vessels, compressing the plaque...
7.
Escuer J, Aznar I, McCormick C, Pena E, McGinty S, Martinez M
Biomech Model Mechanobiol
. 2021 Feb;
20(2):767-786.
PMID: 33533998
In the last decade, many computational models have been developed to describe the transport of drug eluted from stents and the subsequent uptake into arterial tissue. Each of these models...
8.
Rolls D, Khanna S, Lloyd N, Reeson A, Jayasena R, McCormick C, et al.
Int J Med Inform
. 2019 Dec;
134:104042.
PMID: 31855847
Purpose: To investigate whether the installation of electronic patient journey boards in an inpatient adult rehabilitation centre in Victoria, Australia, is associated with shorter lengths of stay for admitted adult...
9.
McKittrick C, McKee S, Kennedy S, Oldroyd K, Wheel M, Pontrelli G, et al.
J Control Release
. 2019 Mar;
303:151-161.
PMID: 30878363
In this study, we developed a predictive model of in vivo stent based drug release and distribution that is capable of providing useful insights into performance. In a combined mathematical...
10.
Holland I, Logan J, Shi J, McCormick C, Liu D, Shu W
Biodes Manuf
. 2018 Dec;
1(2):89-100.
PMID: 30546921
The therapeutic replacement of diseased tubular tissue is hindered by the availability and suitability of current donor, autologous and synthetically derived protheses. Artificially created, tissue engineered, constructs have the potential...